lupus Archives -

Market Access/ News/ News

Otsuka, Aurinia claim EU okay for oral lupus nephritis drug

Phil Taylor Aurinia, EU, Lupkynis, lupus, lupus nephritis, Otsuka, regulatory approval 0 Comment

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral

Otsuka, Aurinia claim EU okay for oral lupus nephritis drug

https://pharmaphorum.com/news/otsuka-aurinia-claim-eu-okay-for-oral-lupus-drug/

Image highlighting acute pain in the palm of a woman's hand

News/ News/ Press Releases/ R&D

Hope for lupus sufferers with Feinstein Institutes-led phase 2 trial

Nicole Raleigh autoimmune, cutaneous, Feinstein Institutes, inflammation, litifilimab, lupus, Northwell Health, systemic 0 Comment

Findings from the litifilimab trial, undertaken by Northwell Health’s Division of Rheumatology and The Feinstein Institutes for Medical

Hope for lupus sufferers with Feinstein Institutes-led phase 2 trial

https://pharmaphorum.com/news/hope-for-lupus-sufferers-with-feinstein-institutes-led-phase-2-trial/

Digital/ News/ News

Akili digital therapeutic shows promise in lupus patients

Phil Taylor Akili Interactive, autoimmune disease, cognition, digital, digital health, digital therapeutics, lupus 0 Comment

Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the

Akili digital therapeutic shows promise in lupus patients

https://pharmaphorum.com/news/akili-digital-therapeutic-shows-promise-in-lupus-patients/

Market Access/ News/ News

AZ’s lupus drug Saphnelo cleared in EU, challenging GSK’s Benlysta

Phil Taylor AstraZeneca, Benlysta, EU, GlaxoSmithKline, lupus, regulatory approval, Saphnelo 0 Comment

AstraZeneca’s Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus

AZ’s lupus drug Saphnelo cleared in EU, challenging GSK’s Benlysta

https://pharmaphorum.com/news/azs-saphnelo-is-cleared-in-eu-challenging-gsks-benlysta/

AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

Market Access/ News/ News

FDA approves AZ’s anifrolumab, ending 10-year lupus drug drought

Phil Taylor anifrolumab, AstraZeneca, fda, lupus, lupus nephritis, regulatory approval, Saphnelo 0 Comment

AstraZeneca has completed the resurrection of its anifrolumab drug for systemic lupus erythematosus (SLE) after claiming FDA approval

FDA approves AZ’s anifrolumab, ending 10-year lupus drug drought

https://pharmaphorum.com/news/fda-approves-azs-anifromulab-ending-10-year-lupus-drug-drought/

News/ News/ R&D

Merck takes on Lilly/Nektar in IL-2 with $1.85bn Pandion buy

Phil Taylor autoimmune disease, lupus, M&A, Merck & Co, Pandion Therapeutics, ulcerative colitis 0 Comment

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for

Merck takes on Lilly/Nektar in IL-2 with $1.85bn Pandion buy

https://pharmaphorum.com/news/merck-takes-on-lilly-nektar-in-il-2-with-1-85bn-pandion-buy/

Market Access/ News/ News

GSK’s Benlysta claims first FDA okay for lupus kidney damage

Phil Taylor Benlysta, fda, GlaxoSmithKline, lupus, lupus nephritis 0 Comment

GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up

GSK’s Benlysta claims first FDA okay for lupus kidney damage

https://pharmaphorum.com/news/gsks-benlysta-claims-first-fda-okay-for-lupus-kidney-damage/

Events/ Events/ Patients

PREDiCT: Autoimmune Disease Modeling Summit

jenna.warren@hansonwade.com autoimmune, Diabetes, IBD, lupus, Sclerosis 0 Comment

Deploy Advanced Models to Enhance Your Confidence & Und

PREDiCT: Autoimmune Disease Modeling Summit

https://pharmaphorum.com/events/predict-autoimmune-disease-modeling-summit/

News/ News/ R&D

AZ fleshes out positive trial of revitalised lupus drug anifrolumab

Phil Taylor AstraZeneca, autoimmune disease, Gazyvaro, lupus, lupus nephritis, Roche 0 Comment

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest

AZ fleshes out positive trial of revitalised lupus drug anifrolumab

https://pharmaphorum.com/news/az-fleshes-out-positive-trial-of-revitalised-lupus-drug-anifrolumab/

Trending

lupus

Login